NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

526 hedge funds and large institutions have $10.7B invested in Neurocrine Biosciences in 2022 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 194 increasing their positions, 169 reducing their positions, and 39 closing their positions.

Holders
526
Holders Change
+62
Holders Change %
+13.36%
% of All Funds
8.49%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.15%
New
107
Increased
194
Reduced
169
Closed
39
Calls
$38M
Puts
$3.89M
Net Calls
+$34.1M
Net Calls Change
+$26.4M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$245M
2
BlackRock
2
BlackRock
New York
$1.51B
3
Invesco
3
Invesco
Georgia
$170M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$93.9M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$144M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$289M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$0
3
AC
3
Armistice Capital
New York
$107M
4
Franklin Resources
4
Franklin Resources
California
$82.9M
5
ITP
5
Iron Triangle Partners
Connecticut
$12M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$1.51B 12,627,653 +580,508 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.12B 9,340,295 +339,332 +4%
State Street
3
State Street
Massachusetts
$446M 3,730,186 -36,535 -1%
BG
4
Bellevue Group
Switzerland
$331M 2,773,294 -81,852 -3%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$289M 2,415,638 -7,438,030 -75%
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$259M 2,170,062 -201,175 -8%
Morgan Stanley
7
Morgan Stanley
New York
$245M 2,048,085 +1,511,307 +282%
APM
8
Avidity Partners Management
Texas
$213M 1,780,000 -75,700 -4%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$201M 1,684,723 -56,232 -3%
Renaissance Technologies
10
Renaissance Technologies
New York
$193M 1,613,664 +171,200 +12%
DM
11
Deerfield Management
New York
$181M 1,512,714 – –
Invesco
12
Invesco
Georgia
$170M 1,427,279 +521,568 +58%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$170M 1,425,290 -38,124 -3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$166M 1,388,695 +71,001 +5%
DCP
15
DSM Capital Partners
Florida
$159M 1,332,703 +10,501 +0.8%
Goldman Sachs
16
Goldman Sachs
New York
$159M 1,329,722 +127,932 +11%
Wellington Management Group
17
Wellington Management Group
Massachusetts
$144M 1,206,053 +436,603 +57%
RSCM
18
Rock Springs Capital Management
Maryland
$134M 1,122,500 – –
Brown Advisory
19
Brown Advisory
Maryland
$127M 1,061,661 -13,265 -1%
Norges Bank
20
Norges Bank
Norway
$112M 935,915 +62,242 +7%
CAM
21
Congress Asset Management
Massachusetts
$110M 917,825 -176,352 -16%
AC
22
Armistice Capital
New York
$107M 900,000 -424,000 -32%
Northern Trust
23
Northern Trust
Illinois
$103M 861,542 +3,387 +0.4%
Amundi
24
Amundi
France
$102M 923,366 +106,554 +13%
Millennium Management
25
Millennium Management
New York
$100M 840,340 +267,284 +47%
1
2 3 4 5